DECIPHERA PHARMACEUTICALS IN (DCPH) Stock Analyst Earnings Estimates
NASDAQ:DCPH - Nasdaq - US24344T1016 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 96.148M 128.45% | 134.036M 39.41% | 163.356M 21.87% | 205.66M 25.90% | 264.6M 28.66% | 382.46M 44.54% | 434.31M 13.56% | 509.33M 17.27% | 610.88M 19.94% | 715.74M 17.17% | 1.039B 45.16% | |
| EBITDA YoY % growth | -297.063M -10.48% | -179.776M 39.48% | -208.858M -16.18% | -206.04M 1.35% | -208.08M -0.99% | -184.62M 11.27% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -300.077M -10.65% | -182.722M 39.11% | -210.958M -15.45% | -203.205M 3.68% | -168.305M 17.17% | -73.214M 56.50% | -25.102M 65.71% | 53.931M 314.85% | 157.78M 192.56% | 267.94M 69.82% | 538.56M 101.00% | |
| Operating Margin | -312.10% | -136.32% | -129.14% | -98.81% | -63.61% | -19.14% | -5.78% | 10.59% | 25.83% | 37.44% | 51.83% | |
| EPS YoY % growth | -5.15 -7.52% | -2.55 50.49% | -2.29 10.20% | -2.17 5.08% | -1.59 27.06% | -0.59 63.05% | -0.45 23.82% | 0.71 258.29% | 1.58 123.83% | 2.60 64.52% | 4.04 55.29% |
All data in USD
| Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 9.33% | -0.53 9.15% | -0.55 -1.16% | -0.47 9.77% | -0.44 15.13% | -0.33 38.06% | -0.08 85.06% |
| Revenue Q2Q % growth | 50.622M 32.16% | 53.839M 24.30% | 54.858M 13.59% | 49.556M 16.47% | 55.699M 10.03% | 68.122M 26.53% | 89.5M 63.15% |
| EBITDA Q2Q % growth | -49.98M 3.13% | -51M 2.01% | -54.06M -10.02% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.106M 6.95% | -49.524M 7.76% | -52.484M -2.43% | -49.558M -1.45% | -46.642M 5.02% | -35.814M 27.68% | -12.61M 75.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | -0.52 13.33% | -0.57 | 0.05 | 8.03% |
| Q4 2023 Q2Q % growth | -0.54 10.00% | -0.59 | 0.05 | 8.79% |
| Q3 2023 Q2Q % growth | -0.58 -5.45% | -0.62 | 0.04 | 6.60% |
| Q2 2023 Q2Q % growth | -0.57 5.00% | -0.63 | 0.06 | 9.87% |
| Q1 2023 Q2Q % growth | -0.60 25.00% | -0.61 | 0.01 | 0.83% |
| Q4 2022 Q2Q % growth | -0.60 60.26% | -0.57 | -0.03 | -5.50% |
| Q3 2022 Q2Q % growth | -0.55 59.85% | -0.59 | 0.04 | 6.44% |
| Q2 2022 Q2Q % growth | -0.60 50.41% | -0.67 | 0.07 | 10.60% |
| Q1 2022 Q2Q % growth | -0.80 24.53% | -0.92 | 0.12 | 12.94% |
| Q4 2021 Q2Q % growth | -1.51 -37.27% | -1.41 | -0.10 | -7.35% |
| Q3 2021 Q2Q % growth | -1.37 -21.24% | -1.30 | -0.07 | -5.26% |
| Q2 2021 Q2Q % growth | -1.21 -0.83% | -1.18 | -0.03 | -2.71% |
| Q1 2021 Q2Q % growth | -1.06 22.06% | -1.08 | 0.02 | 2.28% |
| Q4 2020 Q2Q % growth | -1.10 16.03% | -1.17 | 0.07 | 6.37% |
| Q3 2020 Q2Q % growth | -1.13 11.72% | -1.33 | 0.20 | 14.72% |
| Q2 2020 Q2Q % growth | -1.20 -114.29% | -1.39 | 0.19 | 13.94% |
| Q1 2020 Q2Q % growth | -1.36 -8.80% | -1.28 | -0.08 | -6.24% |
| Q4 2019 Q2Q % growth | -1.31 | -1.20 | -0.11 | -8.99% |
| Q3 2019 Q2Q % growth | -1.28 | -1.16 | -0.12 | -10.32% |
| Q2 2019 Q2Q % growth | -0.56 | -1.13 | 0.57 | 50.40% |
| Q1 2019 Q2Q % growth | -1.25 | -0.86 | -0.39 | -45.72% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q1 2024 Q2Q % growth | 42.55M 27.22% | 47.202M | -4.652M | -9.86% |
| Q4 2023 Q2Q % growth | 48.295M 32.88% | 46.837M | 1.458M | 3.11% |
| Q3 2023 Q2Q % growth | 43.313M 20.40% | 40.189M | 3.124M | 7.77% |
| Q2 2023 Q2Q % growth | 38.304M 17.88% | 36.602M | 1.702M | 4.65% |
| Q1 2023 Q2Q % growth | 33.445M 14.45% | 36.512M | -3.067M | -8.40% |
| Q4 2022 Q2Q % growth | 36.345M 50.19% | 36.463M | -118K | -0.32% |
| Q3 2022 Q2Q % growth | 35.974M 54.93% | 33.817M | 2.157M | 6.38% |
| Q2 2022 Q2Q % growth | 32.494M 37.84% | 31.115M | 1.379M | 4.43% |
| Q1 2022 Q2Q % growth | 29.223M 16.17% | 26.961M | 2.262M | 8.39% |
| Q4 2021 Q2Q % growth | 24.199M 24.19% | 23.752M | 447K | 1.88% |
| Q3 2021 Q2Q % growth | 23.22M 50.30% | 23.825M | -605K | -2.54% |
| Q2 2021 Q2Q % growth | 23.573M 232.48% | 22.32M | 1.253M | 5.61% |
| Q1 2021 Q2Q % growth | 25.156M 40,474.19% | 23.04M | 2.116M | 9.18% |
| Q4 2020 Q2Q % growth | 19.486M | 19.305M | 181K | 0.94% |
| Q3 2020 Q2Q % growth | 15.449M | 7.191M | 8.258M | 114.84% |
| Q2 2020 Q2Q % growth | 7.09M -71.64% | 907.8K | 6.182M | 681.01% |
| Q1 2020 Q2Q % growth | 62K | 212.497K | -150.497K | -70.82% |
| Q4 2019 Q2Q % growth | 1.177M | -1.177M | -100.00% | |
| Q3 2019 Q2Q % growth | 463.641K | -463.641K | -100.00% | |
| Q2 2019 Q2Q % growth | 25M | 2.04M | 22.96M | 1,125.49% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 9.43% | 8.94% | 1.43% | 3.18% |
| Revenue | 2.15% | 1.7% | 0.68% | 0.89% |